Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: IMX-110 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for IMX-110 in adults with advanced solid tumors across Phase 1 and Phase 2 is listed, with multiple solid tumor ind…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor [Phase 2]
Phase 2 trial evaluating camrelizumab and famitinib in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update reporting a Phase 1/2 study of QLS31905 in combination chemotherapy as first-line treatment for advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for 7MW3711 in advanced solid tumors is reported, with status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Study of 7MW3711 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for 7MW3711 in subjects with advanced solid tumors (Phase 1/Phase 2) with unknown status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors [Phase 2]
Phase 2 clinical trial update for pemigatinib in solid tumors with FGF/FGFR alterations; status and conditions are reported but final result…
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors [Phase 1]
Phase 1 study of HS130 in combination with Viagenpumatucel-L (HS110) in patients with advanced solid tumors has been completed with results …
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: AO-176 in Multiple Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 trial update for AO-176 in solid tumor malignancies completed.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers [Phase 2]
Phase 2 clinical trial update for a MUC1 therapeutic tumor vaccine in adults with solid tumors.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
An early-phase study evaluating IMX-110 in combination with tislelizumab in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation [Phase 1, Phase 2]
Phase I/II clinical trial update for YL-15293 in patients with advanced solid tumors harboring KRAS mutations.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: M6620 (VX-970) in Selected Solid Tumors [Phase 2]
Phase 2 trial of M6620 (VX-970) in selected solid tumors completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: ALG.APV-527 First-in-human Study [Phase 1, Phase 2]
First-in-human study update for ALG.APV-527 investigating solid tumors in Phase 1/Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors [Phase 1, Phase 2]
Early-stage trial updating on combining stereotactic body radiotherapy with cadonilimab for advanced solid tumors, across Phase 1 and Phase …
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for JBI-802, an LSD1/HDAC6 inhibitor, in locally advanced or metastatic solid tumors. No current status avai…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 [Phase 1, Phase 2]
A study evaluating the safety and efficacy of Debio 1143, a SMAC mimetic, in solid tumors has completed Phase 1/2 with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Effect of Refnot on Immunity in Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating Refnot on immunity in cancer patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for BPB-101 in subjects with solid tumors (Phase 1/Phase 2); status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study evaluating SHR-1802 in combination with adebrelimab in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II study of HS-10365 in patients with advanced solid tumors is reported as an early clinical trial update with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating IMM01 in combination with tislelizumab for advanced solid tumors and Classic Hodgkin lymphoma is ongoing with unk…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors [Phase 2, Phase 3]
Phase 2/3 trial update evaluating inosine (gut microbial metabolite) in combination with PD-1/PD-L1 inhibitors for patients with advanced so…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 [Phase 1, Phase 2]
Phase 1/2 trial update for IMM2902 in patients with HER2-expressing advanced solid tumors including advanced solid tumors, advanced lung can…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: A Study of DB-1202 Monotherapy in Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for DB-1202 monotherapy in advanced solid tumors spanning Phase 1 and Phase 2; current status is UNKNOWN.